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Actions of Melanotropins on Mouse Melanoma Cell 
Growth In Vitro 1,2 
Zalfa A. Abdel Malek,3 Mac E. Hadley,3,4 Marvin D. Bregman, 5 
Frank L. Meyskens, Jr.,5 and Victor J. Hruby 6,7 
ABSTRACT -Melanotropins induce melanogenesis in mouse 
Cloud man S91 melanoma cells by stimulating the activity of tyro-
sinase. In monolayer culture, a-melanocyte-stimulating hor-
mone and the superpotent analogue 4-norleucine, 7-o-phenyl-
alanine-a-melanocyte, which had prolonged effects on tyrosinase 
activity, did not inhibit the proliferation of melanoma cells even at 
concentrations that elicited maximal tyrosinase stimulation. In soft 
agar the melanotropins stimulated the formation of melanized colo-
nies and increased the cloning and proliferative potentials of mel-
anoma cells. Both melanotropins increased the number of small 
(42-104 I'm in diameter) colonies at initial plating densities rang-
ing from 625 to 7,500 cells/dish. The number of larger (>104 I'm in 
diameter) colonies was also increased except at densities 5,000 
cells or more/dish, wherein the proliferative capacity was inhibited; 
yet the cloning efficiency was still increased. Therefore, in bilayer 
soft agar cultures, melanotropins stimulate the growth of the clono-
genic S91 melanoma cell population under conditions that allow 
for optimal expression of the cloning and proliferative potentials of 
these cells.-JNCI1986; 76:857-863. 
Melanotropic peptides such as a-MSH are known to 
induce melanogenesis within integumental melanocytes 
(1, 2). Likewise, in Cloudman S91 murine melanoma, 
a-MSH has been shown to stimulate melanin synthesis, 
an effect that can be monitored by measuring the 
increase in the activity of tyrosinase, the rate-limiting 
enzyme of the melanin biosynthetic pathway (3). 
The mechanism of action of a-MSH involves binding 
of the hormone to specific membrane receptors. This 
initial event results in stimulation of adenylate cyclase 
activity and in increased production of intracellular 
cAMP. The elevated cAMP levels trigger a cascade of 
phosphorylation events that lead to stimulation of 
transcriptional and translational processes that result in 
increased tyrosinase activity (3). The effect of a-MSH on 
the growth (proliferation) of melanoma cells has been a 
controversial issue. Numerous reports exist on the in-
hibitory effects of a-MSH on the proliferation of mela-
noma cells (3-8). However, this inhibition has been 
observed in vitro, not in vivo (3, 4, 8), and has been 
attributed to several factors, the most important of 
which are cell density, infrequent change of the culture 
medium (feeding), and accumulation of by-products of 
melanin synthesis (9). Evidence for the toxicity of 
melanin by-products comes from the observation that 
some of these intermediates, like L-DOPA and 5,6-
dihydroxyindole, retard the growth of S91 melanoma 
cells (10). It has been shown that a-MSH can either 
stimulate or inhibit the proliferation of S91 melanoma 
cells depending on the culture conditions under which 
the cells are maintained, such as the frequency of refeed-
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ing and the level of tyrosine, the substrate for melanin 
formation, in the culture medium (9). 
To further investigate these problems, we have exam-
ined the relative effects of a-MSH and the superpotent 
analogue [Nle\ D-Phe7]-a-MSH on the growth of S91 
(CCL 53.1) cells in monolayer culture as well as in 
bilayer (soft agar) culture. [Nle4, D-Phe7]-a-MSH has 
been shown to be more potent than the native hormone 
a-MSH in several melanocyte bioassays (11, 12). This 
peptide is at least one hundredfold-more effective than 
a-MSH in stimulating S91 melanoma cell tyrosinase 
activity (13). This hormone analogue also exhibits 
ultraprolonged effects (also called "residual activity") 
on tyrosinase activity. [Nle4, D-Phe7]-a-MSH is therefore 
considered a potentially important investigative probe 
for studies on the factors affecting melanoma cell prolif-
eration in two diverse culture systems: monolayer and 
bilayer soft agar cultures. The results shed new light on 
the proliferative response of melanoma cells exposed to 
melanotropins as affected by culture conditions. 
MATERIALS AND METHODS 
Materials.-Ham's medium FlO and penicillin and 
streptomycin solution (100 D/ml and 100 JLg/ml, respec-
tively) were purchased from GIBCO (Santa Clara, CA). 
Fetal bovine and horse sera were either obtained from 
GIBCO or from KC Biologicals (Lenexa, KS). [3',5'-
3H]Tyrosine (sp act, 53.8 Ci/mmol) was obtained from 
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[Nle4, D-Phe7]-a-MSH = 4-norleucine, 7 -D-phenylalanine-a-MSH. 
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New England Nuclear (Boston, MA), and o:-MSH was 
purchased from Sigma Chemical Co. (St. Louis, MO). 
[Nle4, D-Phe7]-o:-MSH was synthesized as described pre-
viously (11,12). 
Stock cultures.-Cloudman S91 3960, CCL 53.1, is a 
moderately melanotic murine melanoma cell line that 
was obtained from the American Type Culture Collec-
tion Repository (Rockville, MD) and has been alter-
nately maintained by limited subculturing as monolay-
ers or as tumors in syngeneic DBA/2J mice. All experi-
ments were performed on early passage «10) cells to 
minimize phenotypic drift that is often observed in 
long-term cultures. Cells were grown in Ham's medium 
FlO supplemented with 10% horse serum and 2% fetal 
calf serum, both heat inactivated at 56°C for 30 minutes 
to prevent the degradation of o:-MSH by serum enzymes. 
The medium was also supplemented with 100 U penicil-
lin/ml and 100 p,g streptomycin/m!. Cells were incu-
bated at 37°C in a humid atmosphere of 5% CO2 and 
95% air. 
Effects of melanotropins on monolayer cultures of S91 
eeL cells.-The prolonged effects of o:-MSH and [Nle4, 
D-Phe7]-o:-MSH on tyrosinase activity were determined 
by seeding cells at 2X 105 cells/2S-cm2 flask in 4 ml 
medium and treating them the next day with the 
melanotropins (10-7 M) for 24 hours. The melano-
tropins were removed from the culture flasks prior to 
determining their prolonged effects. The flasks were 
rinsed with melanotropin-free media several times until 
no melanotropic activity could be detected in the incu-
bation media by the frog skin bioassay. This assay is 
sensitive to melanotropin concentrations at least tenfold 
lower than the minimal effective dose required to stimu-
late tyrosinase activity. The medium in all flasks was 
changed daily, and medium containing [3H]tyrosine at 
1 p,Ci/ml (i.e., 4 p,Ci/flask) was added to a set of control 
and experimental flasks 24 hours prior to data collection. 
For experiments involving 6-day exposure to o:-MSH 
or [Nle4, D-Phe7]-o:-MSH, cells were seeded at 2X 105 
cells/2S-cm2 flask and were allowed to attach overnight. 
Then the medium was removed and replaced with fresh 
medium with the appropriate melanotropin added at 
10-7 M each day thereafter. Twenty-four hours before 
data collection, the medium was replaced with medium 
containing [3H]tyrosine (1 p,Ci/ml) as well as the mela-
notropin. At the end of each exposure period, the 
labeled medium from each flask was collected for assay 
of tyrosinase activity and the cells were harvested with 
EDTA-containing Tyrode's solution and counted with 
the aid of a hemacytometer. 
Tyrosinase assay.-Tyrosinase activity was determined 
by using a modification of the charcoal absorption 
method of Pomerantz (14), which measures the amount 
of 3H20 released during the conversion of [3H]tyrosine 
to L-DOPA, a reaction catalyzed by tyrosinase. Duplicate 
I-ml samples were taken from each flask, and each sam-
ple was treated with 1 ml of activated charcoal (10% 
wt/vol in 0.2 N citric acid) and centrifuged. From each 
sample, 1 ml of the supernatant was passed through a 
Dowex 50 W column. The columns were then rinsed 
JNCI, VOL. 76, NO.5, MAY 1986 
with 1 ml of 0.1 N citric acid, and the eluents were col-
lected into scintillation vials that received 12 ml of scin-
tillation fluid [toluene: Triton X-100, 2:1 vol/vol, plus 
5.5 g 2,S-diphenyl-l,3-oxazole/liter (Beckman Instru-
ments, Inc., Fullerton, CA)] and were counted in a 
Beckman LS-8000 scintillation spectrometer. Tyrosinase 
activity was expressed as cpm/l06 cells and then as a 
percent of control enzyme activity. 
Effects of melanotropins on bilayer agar cultures.-
The colony-forming assay may be the best in vitro test to 
determine cellular transformation (15). This assay has 
been used to study the chemosensitivity of human tumor 
cells to various drugs (16, 17) and to determine the 
effects of biologic modifiers on the clonogenic potential 
of melanoma cells (18-20). The effects of melanotropins 
on the ability of S91 melanoma cells to form colonies in 
soft agar were determined by plating a known number 
of cells into 30-mm diameter petri dishes in 1 ml of 
0.3% agar in serum-supplemented Ham's medium FlO 
over an underlayer of 1 ml of the same medium with 
O.S% agar. Cultures were continuously exposed to the 
appropriate melanotropin and were incubated for 
10 days. It has been observed that the proliferation of 
S91 CCL cells is rapidly initiated and that about 40% of 
the cells plated divide once after 1 day in agar and con-
tinue to divide approximately every 32 hours (21). A 
sequential increase in the size of growth units is 
observed until proliferation stops 9 days after plating. 
After 10 days of incubation, colonies were counted and 
grouped into two categories according to diameter 
(42-104 p,m and >104 p,m) with the FAS II (Bausch and 
Lomb, Inc., Rochester, NY) optical image analyzer (22). 
By using a nomogram that we have established, In (No. 
of cells/growth unit)=0.87-2.80 In (cell diameter) + 
2.38 In (growth unit diameter), the number of cells per 
growth unit could be calculated (23). From this equa-
tion, it can be determined that CCL growth units greater 
in diameter than 42 p,m are composed of at least 10 cells, 
which corresponds to three divisions, and that growth 
units greater than 104 p,m in diameter contain at least 
lOS cells, the outcome of 6-cell divisions. 
RESULTS 
In the present study, the effects of o:-MSH and the 
potent analogue [Nle4, D-Phe7]-o:-MSH on melanogene-
sis and proliferation of Cloudman S91 cells were deter-
mined. [Nle4, D-Phe7]-o:-MSH was shown to be about 
one hundredfold more potent than o:-MSH in stimulat-
ing tyrosinase activity of CCL cells (13). This analogue 
also exhibited ultraprolonged activation of tyrosinase, as 
enzyme activity was maintained for days after initial 
contact of the cells with the peptide and after removal of 
the melanotropin from the culture medium. Upon treat-
ing CCL cells with 10-7 M [Nle4, D-Phe7]-o:-MSH for 
24 hours, we elicited a twofold increase in enzymatic 
activity above basal level 24 hours following removal of 
the melanotropin from the culture medium. Tyrosinase 
activity was further increased after 48 hours and re-
mained remarkably elevated above control for 4 days in 
the absence of [Nle\ D-Phe7)-a-MSH (text-fig. 1). Under 
these monolayer culture conditions and despite near-
maximal enzymatic activation, the rate of proliferation 
of melanotropin-treated cells was not inhibited (or 
reduced) relative to the growth rate of untreated (con-
trol) cells (text-fig. 2). 
The proliferation of CCL cells in monolayer culture 
was not retarded even with continuous and daily expo-
sure to lO-7 M a-MSH or [Nle4, D-Phe7]-a-MSH. After 
72 and 96 hours of exposure to either melanotropin, ty-
rosinase activity was maximally stimulated eightfold to 
ninefold above basal levels (text-fig. 3). At these exposure 
periods the melanotropins did not inhibit the prolifera-
tive rate of CCL cells. Even after 6 days of contact with 
either a-MSH or [Nle4, D-Phe7)-a-MSH, cellular growth 
in melanotropin-treated flasks was comparable to that 
observed in control cultures (text-fig. 4). As shown in 
text-figures 2 and 4, in the presence or absence of mela-
notropins these cells in monolayer have a doubling time 
of about 24 hours during log phase of growth (i.e., days 
1-5). 
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TEXT·FIGURE 2.-Cells were seeded at O.SXI01 cells/cm2 and were 
treated the next day with 10-7 M [Nle4, D-Phe7]-a-MSH for 24 hr. 
after which time the melanotropin analogue was removed from the 
culture flasks. Cell density/cm2 was determined by counting the 
number of cells/flask with the aid of a hemacytometer 24 hr after 
melanotropin removal and daily thereafter for 3 more days. Each 
value (vertical bar) represents the mean cell density/cm2 (XI01) ± 
SE of 3 determinations (i.e., of triplicate flasks) for the control and 
the melanotropin-treated [Nle4, D-Phe7]-0!-MSH flasks. 
Further evidence for a lack of growth inhibition of 
S91 melanoma cells by melanotropins came from studies 
on the effects of a-MSH and [Nle4, D-Phe7)-a-MSH on 
the ability of CCL cells to clone and proliferate in soft 
agar. Cells were plated at 5,000 cells/dish and continu-
ously treated with different concentrations of a-MSH 
and [Nle4, D-Phe7)-a-MSH. This resulted in the forma-
tion of extremely melanized colonies and in the stimula-
tion of cloning efficiency as evidenced by an increase in 
the total number of colonies/dish (42-lO4 p.m in di-
ameter; table 1). The proliferative capacity of melanoma 
cells (i.e., formation of colonies with diameters greater 
than 104 p.m) was not affected by a-MSH but was, how-
ever, inhibited by higher concentrations (2:10-8 M) of 
[N I e4, D-Phe7)-a-MSH (table 1). 
Knowing that the size of growth units decreases with 
increased plating density (17, 21), we plated the cells at 
different cell densities and continuously treated them 
with lO-7 M a-MSH or [Nle4, D-Phe7)-a-MSH. At plat-
ing densities lower than 5,000 cells/dish, both melano-
tropins stimulated the cloning efficiency, as well as the 
proliferative capacity of the melanoma colony-forming 
cells (text-figs. 5, 6). The proliferative capacity of CCL 
cells was inhibited by melanotropins only when the 
initial plating density was equivalent to or exceeded 
5,000 cells/dish, although at these densities the cloning 
efficiency was still increased (text-figs. 5, 6). These 
JNCI, VOL. 76. NO.5, MAY 1986 
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TEXT·FIGURE 3.-Stimulation of tyrosinase activity by continuous 
exposure for 6 days to 10-7 M a-MSH or [Nle4, D-Phe7]-a-MSH. 
Cells were seeded into flasks and were treated the next day with 10-7 
M a-MSH or [Nle4, D-Phe7]-a-MSH for 24 hr and daily thereafter for 
6 days. Tyrosinase activity was determined daily and was first 
expressed as cpm/106 cells and then as percent of control (basal) 
activity. Each value (vertical bar) represents the mean percent of 
control ± SE of 6 determinations. 
TEXT-FIGURE 4.-Cells were seeded at 0.SXI04 cells/cm2 and were 
treated the next day with 10-7 M a-MSH or [Nle4, D-Phe7]-a-MSH. 
Cells were maintained in the presence of the melanotropins for 6 
consecutive days, with medium in each flask changed and with fresh 
melanotropins added daily. Number of cells/flask was determined 
daily with the aid of a hemacytometer. Each value (vertical bar) 
represents the mean cell density/cm2 ± SE of 3 determinations (i.e., 
triplicate flasks). 
DISCUSSION results indicate that melanotropins are indeed stimula-
tory to the growth of S91 melanoma cells in soft agar 
under conditions that allow for optimal expression of 
their cloning and proliferative potentials. 
a-MSH-induced stimulation of tyrosinase activity, 
and thus melanogenesis, in murine melanoma cells has 
TABLE l.-Effects of melanotropins on the clonogenic potential and the proliferative capacity of melanoma cells plated in soft agara 
Concentration, M 
Control 
a-MSH,1O-9 
a-MSH,1O-8 
a-MSH,1O-7 
a-MSH,1O-6 
[Nle4, D-Phe7 ]-a-MSH, 10-11 
[Nle\ D-Phe7 ]-a-MSH, 10-9 
[Nle4, D-Phe7 ]-a-MSH, 10-8 
[Nle\ D-Phe7]-a-MSH, 10-7 
[Nle4, D-Phe7 ]-a-MSH, 10-6 
No. of colonies with 
diameter 42-104 /Lm/dishb 
684±28 
756±72 
1,042±42 
1,764±90 
1,536±46 
1,026±86 
1,468±74 
1,292±146 
1,286±64 
1,610±38 
No. of colonies with 
diameter> 104 /Lm/dish b 
652±46 
880±126 
600±16 
636±22 
588±74 
688±20 
614±70 
468±36 
576±24 
468±8 
a Cells were plated at 5,000 cells/dish and were continuously exposed to the above concentrations of a-MSH or [Nle4 , D-Phe7]-a-MSH. After 
10 days of incubation, the colonies were counted and grouped into two categories according to diameter (42-104 and ~104 /Lm). 
b Each value represents the mean number of colonies/dish ± SE of 6 determinations for the control group and of 3 determinations for the 
melanotropin-treated groups. 
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TEXT· FIGURE 5.-Number of colonies with diameters of 42-104 /Lm. 
Response of cells plated at different densities in soft agar to 
continuous exposure to me1anotropins. Cells were plated in soft 
agar at 625, 1,250, 2,500, 5,000, and 7,500 cells/dish and were 
continuously exposed to 10-7 M a-MSH or [Nle4, D-Phe7l-a-MSH. 
After 10 days of incubation, the colonies in each dish were counted 
and grouped into two categories according to diameter. Vertical bar, 
mean ± SE. 
often been correlated with growth inhibition (decreased 
proliferative capacity). However, in both Cloudman S91 
and B16 melanoma, the inhibitory effect of a-MSH on 
proliferation has been observed in vitro, not in vivo (3, 
4, 8). In S91 melanoma, a-MSH did not affect the rate of 
tumor growth in vivo (3, 4). In this tumor type, how-
ever, growth was reported to be inhibited when a-MSH 
treatment was accompanied by feeding tumor-bearing 
mice a tyrosine-rich diet, while melanoma tumors in 
animals maintained on a regular diet were not reduced 
in size with a-MSH treatment. 
Melanotroplns and Melanoma Cell Growth 861 
In the present experiments, the S91 melanoma CCL, 
which has a moderate basal tyrosinase activity and a 
doubling time of about 24 hours, responded to treatment 
with [Nle4, D-Phe7]-a-MSH with about a fourfold in-
crease in tyrosinase activity, which was maintained for 
days after the melanotropin analogue was removed from 
the culture flasks (text-fig. 1). However, contrary to 
many previous reports, these effects were not accom-
panied by retardation of proliferation in monolayer cul-
ture (text-fig. 2). With continuous exposure to melano-
tropins, the rate of cell growth was not reduced even 
when cultures approached confluency (text-fig. 4), a 
result that contrasts with other investigators' findings 
relative to retardation of S91 melanoma cell prolifera-
tion by prolonged (;::::3 days) melanotropin treatment (5, 
24). Fuller and Lebowitz also noted that a-MSH failed 
to affect proliferation in this melanoma cell line (25). 
The lack of inhibition of cellular proliferation in our 
experiments might be attributed to daily supplementa-
tion of the cells with fresh media, thus replenishing 
essential nutrients and removing any accumulated meta-
bolic by-products. Actually, it is possible that, under the 
present monolayer culture conditions, cell division is 
proceeding at such a rapid rate (once every 24 hr) that 
any positive effects that the melanotropins might have 
on growth go· unnoticed. 
In soft agar, both a-MSH and [Nle4, D-Phe7]-a-MSH 
stimulated colony formation and proliferation of cells 
plated at low densities (text-figs. 5,6). Inhibition of pro-
liferation of melanotropin-treated cells was only evident 
when cells were plated at very high densities (;::::5,000 
cells/dish) and treated with high concentrations of 
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TEXT· FIGURE 6.-Number of colonies with diameters> 104 /Lm. See 
text-fig. 5 legend for test and methods used. 
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melanotropins (;:::10-8 M; text-figs. 5, 6; table 1), a con-
dition that may result in cell crowding, depletion of 
nutrients, and accumulation of toxic metabolic by-
products. It has been frequently observed that when the 
initial plating density is very high, the number of cells 
per growth unit is decreased, probably because nutrients 
are exhausted by the large number of single cells plated, 
even before small growth units begin to form. We have 
shown this phenomenon to occur in several cell lines of 
human origin, including, among others, ovarian and 
multiple myeloma, as well as human and murine S91 
melanoma (17, 21). 
The nutritional requirements of eeL cells to clone in 
soft agar are more stringent than their requirements to 
grow in monolayer. In serum-free media, eeL cells 
grow in monolayer and yet fail to clone in agar; how-
ever, the addition of a-MSH allows the colony-forming 
cells to express their cloning and proliferative potential 
in the absence of serum (26). 
Wick has reported that a-MSH does not retard the 
proliferation of S91 melanoma cells plated in soft agar 
and that growth inhibition was only evident when 
a-MSH and theophylline, an agent that mimics or aug-
ments a-MSH effects on melanogenesis, were concomi-
tantly added (27). This observation supports the conclu-
sion that a-MSH does not exert a direct inhibitory effect 
on the proliferative potential of melanoma cells. 
It has been suggested that a-MSH stimulates the 
growth of S91 melanoma cells that have a low basal ty-
rosinase level but inhibits the growth of cells with a 
high basal tyrosinase activity (9). However, we did not 
find such a correlation since a-MSH stimulated the 
growth of eeL cells that have a moderate-to-Iow basal 
tyrosinase activity (text-fig. 1) as well as the growth of a 
highly melanotic S91 cell line that has a high basal ty-
rosinase level (26). It has also been reported that a-MSH 
stimulates the growth of slowly proliferating melanoma 
cells; yet it inhibits that of fast-growing cells (9, 28). Our 
data, however, indicate that melanotropins are stimula-
tory to the growth of eeL cells that divide rapidly in 
monolayer culture (once every 24 hr) and in soft agar 
(once every 32 hr) (21). 
The effect of a-MSH on melanoma cell proliferation 
may be mediated through cAMP. Pawelek et al. have 
reported a biphasic effect of this cyclic nucleotide on S91 
melanoma cells: stimulation of growth at low concen-
trations and inhibition at high concentrations (e.g., fol-
lowing treatment with a-MSH or prostaglandin EI) (28). 
However, in this study, we have shown that neither 
a-MSH nor its potent analogue [Nle4, D-Phe7]-a-MSH, 
both of which increase adenylate cyclase activity (29) 
and thus intracellular cAMP levels, inhibited the growth 
of S91 eeL cells under conditions that allowed optimal 
phenotypic expression (stimulation of melanogenesis 
and colony formation). Also, melanotropins stimulate 
the proliferation of normal epidermal melanocytes in 
amphibians (30). If cAMP is indeed involved in melano-
tropin regulation of melanoma cell growth, then this 
cyclic nucleotide is a growth promoter for S91 mela-
noma cells, in particular, for the eeL utilized in this 
JNCI, VOL. 76, NO.5, MAY 1986 
study. However, this does not seem to be the case, since 
it has previously been reported that prostaglandins, 
which also stimulate melanogenesis via a cAMP-medi-
ated mechanism (31), inhibit the growth of S91 mela-
noma cells (32). 
In a recent report, it was documented that B16 mela-
noma tumors enhance their own growth by secreting an 
insulin-like factor(s) (33). In another report, it was sug-
gested that the ability of transformed cells to clone in 
agar was directly related to the amount of intercellular 
fibronectin (34). Therefore, melanotropins may induce 
colony formation by stimulating the secretion of mela-
noma growth-promoting factors, by increasing the pro-
duction of fibronectin, or by some presently unknown 
mechanism. The present results might support a view 
that, except under conditions wherein nutritive sub-
strates are limiting or where cytotoxic products accumu-
late, the normal physiologic action of melanotropins is 
to enhance melanogenesis, which may be coupled to cel-
lular proliferation. 
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